Ā | Ā | Potentially avoidable * | |
---|---|---|---|
All, Nā=ā137, (%) | Yes, Nā=ā51 (%) | No, Nā=ā86 (%) | |
Irreversible Cancer progression-related symptoms | 35 (25.5) | 30 (58.9) | 5 (5.8) |
Infection, chemotherapy-induced | 23 (16.8) | 2 (3.9) | 21 (24.4) |
Cancer bleeding | 22 (16.1) | 6 (11.8) | 16 (18.6) |
Primary respiratory failure (ex: asphyxia, aspiration etc.) | 14 (10.2) | 6 (11.8) | 8 (9.3) |
Infection, not chemotherapy-induced | 13 (9.5) | 4 (7.9) | 9 (10.5) |
Heart disease | 10 (7.3) | 1 (1.9) | 9 (10.5) |
Respiratory failure due to other disease (e.g.: acute kidney injury due to chemotherapy) | 5 (3.6) | 1 (1.9) | 4 (4.6) |
Procedure/treatment-related complication, except infection (ex: anaphylaxis) | 5 (3.6) | 0 (0) | 5 (5.8) |
Others and unknown | 10 (7.3) | 1 (1.9) | 9 (10.5) |